68 filings
8-K
CHMA
Chiasma, Inc
5 Aug 21
Appoints Raj Kannan and Dr. Roni Mamluk as Non-Executive Directors
5:11pm
8-K
CHMA
Chiasma, Inc
3 Aug 21
Submission of Matters to a Vote of Security Holders
5:15pm
8-K
CHMA
Chiasma, Inc
2 Jul 21
Other Events
4:32pm
8-K
CHMA
Chiasma, Inc
22 Jun 21
Other Events
4:32pm
8-K
CHMA
Chiasma, Inc
5 May 21
Voting and Transaction Support Agreement
5:16pm
8-K
evktrbtxir3atu9
5 May 21
Chiasma Reports First Quarter Financial Results and Announced Agreement to Merge with Amryt
7:33am
8-K
h1xtc
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
7:21am
8-K
j2kwyh 06
4 Mar 21
Chiasma Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Corporate Update
4:08pm
8-K
g8ium1i kgfm366axy9v
19 Jan 21
Chiasma Announces Hiring of John Doyle as Chief Financial Officer
7:07am
8-K
ttc4xu
6 Jan 21
Chiasma Provides Corporate Update and Previews Expected 2021 Milestones
4:28pm
8-K
9bkkoq7zsswj 35t
18 Nov 20
Regulation FD Disclosure
7:06am
8-K
kssr0y8ms
5 Nov 20
Chiasma Reports Third Quarter 2020 Results and Provides MYCAPSSA Launch Update
4:14pm
8-K
zvzvxmg t150
1 Oct 20
Chiasma Announces Planned Transition of Former CEO
7:10am
8-K
fd5faw1c 7na007b9l
10 Aug 20
Chiasma Reports Second Quarter 2020 Results and Significant Progress
4:25pm
8-K
empt24hpk
2 Jul 20
Chiasma Announces Proposed Public Offering of Common Stock andPre-Funded Warrants
12:00am
8-K
2oqgygtp
26 Jun 20
Chiasma Announces FDA Approval of MYCAPSSA® (Octreotide) Capsules, the First and Only Oral
5:04pm
8-K
7mneu10lfo91qumep7
15 Jun 20
Submission of Matters to a Vote of Security Holders
4:07pm
8-K
83m4zw1xzmsui di
7 May 20
Chiasma Reports First Quarter 2020 Financial Results
4:10pm
8-K
kwzw79tm4ryctxnvi
8 Apr 20
Chiasma Enters Into Revenue Interest Financing Agreement for up to $75 Million with Healthcare Royalty Partners
7:05am
8-K
o207ov8tmw1sbrfkz3
16 Mar 20
Chiasma Reports Fourth Quarter and Full Year 2019 Financial Results
4:12pm